River Valley Ingredients, LLC v. American Proteins, Inc.

Superior Court of Delaware·Decided November 5, 2025·No. N19C-12-160 PRW CCLD·Published

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

RIVER VALLEY ) INGREDIENTS, LLC, et al., ) ) Plaintiff/Counter-Defendants, ) ) v. ) C.A. No. N19C-12-160 PRW ) CCLD AMERICAN PROTEINS, INC., et al., ) ) Defendants/Counter-Plaintiffs. )

Submitted: August 12, 2025 Decided: November 5, 2025

Upon Defendants’ Rule 59 Motion for Reargument or, in the Alternative, to Alter or Amend the Judgment, GRANTED in part, DENIED in part.

ORDER

In July 2025, the Court issued its Decision After Trial, in which it found in

favor of Plaintiff Tyson on its fraudulent inducement claim and certain aspects of its

breach-of-contract claim.1 The award to Tyson was $55 million without including

interest.2 After the Court issued this decision, Defendant API filed a Rule 59 motion

for reargument or, in the alternative, to alter or amend the judgment.3

1 River Valley Ingredients, LLC v. Am. Proteins, Inc., 2025 WL 1826656 (Del. Super. Ct. July 2, 2025) (hereinafter “Decision After Trial”). 2 Id. at *21. 3 API’s Rule 59 Mot. (D.I. 691). In its motion, API argues it is due Rule 59 relief because of nine separate

errors it believes the Court made.4 In API’s view, the Court:

(1) “Err[ed] in Using $871 Million as the Represented Value for Damages;”5

(2) “Err[ed] Regarding Application of the Deductible;”6

(3) “Err[ed] in Applying Tyson’s ‘Low Scenario’ Damages”7

(4) “Err[ed] Regarding Mitigation;”8

(5) “Err[ed] in Awarding Compound Pre- and Post-Judgment Interest;”9

(6) “Err[ed] Regarding Timing and Purpose of the Process Change;”10

(7) Made a “Typographical Error Regarding Sample Reliance;”11

(8) “Err[ed] in Finding Sipsey was not Reimbursable;” 12 and,

(9) “Err[ed] in Finding Breach of Art. 4.21(b) without Evidence of Damages”13 Tyson disagrees with all the above, except for the typographical error (Number

4 Id. at 2-13. 5 Id. at 2-3. 6 Id. at 4. 7 Id. at 5-6. 8 Id. at 6-8. 9 Id. at 8. 10 Id. at 8-9. 11 Id. at 9. 12 Id. at 9-10. 13 Id. at 11-12.

-1- Seven).14

For the reasons explained below, API’s motion is GRANTED in part,

DENIED in part.

I. FACTUAL AND PROCEDURAL BACKGROUND

Since the extensive factual and procedural history of this case is set forth in

the re-issued Decision After Trial, it won’t be recounted here. As to the current

motion, the Court heard argument on the pre- and post-judgment interest claim

(Number Five) and informed the parties that it would decide the rest of the Rule 59

issues on the briefing.15

II. STANDARD OF REVIEW

“Under Rule 59, ‘a motion to alter or amend [a] judgment . . . will be granted

if the movant shows: (1) an intervening change in controlling law; (2) the availability

of new evidence; or (3) the need to correct clear error of law or to prevent manifest

injustice.’”16

“A motion for reargument pursuant to Superior Court Civil Rule 59(e) will be

granted only if ‘the Court has overlooked a controlling precedent or legal principles,

or the Court has misapprehended the law or facts such as would have changed the

14 Tyson’s Rule 59 Resp. at 1-10 (D.I. 693). 15 D.I. 696. 16 Monzo v. Nationwide Prop. & Cas. Ins. Co., 249 A.3d 106, 117 (Del. 2021) (citing King v. McKenna, 2015 WL 5168481, at *3 (Del. Super. Ct. Aug. 24, 2015) (citation omitted)).

-2- outcome of the underlying decision.’”17 “A motion for reargument is not an

opportunity for a party to rehash arguments already decided by the Court or to

present new arguments not previously raised.”18

III. DISCUSSION

A. RULE 59 RELIEF IS DUE ON THE INTEREST AND TYPOGRAPHICAL ISSUES.

1. API’s motion to amend the judgment is GRANTED regarding the award of pre- and post-judgment interest. After holding limited post-trial oral argument solely on the judgement interest

issue, the Court finds that compounding interest isn’t warranted in this situation. The

Decision After Trial which has been revised and is reissued herewith further explains

the Court’s reasoning.

2. API’s motion is GRANTED regarding the typographical error regarding sample reliance.

As all agree there was a typographical error transposing the parties in one

sentence, that has been corrected in the Reissued Decision After Trial.

B. NONE OF API’S OTHER ISSUES WARRANT RULE 59 RELIEF.

Most of API’s other current arguments have merely been resurrected from its

post-trial briefing. None demonstrate proper grounds to grant it Rule 59 relief.

17 Strong v. Wells Fargo Bank, 2013 WL 1228028, at *1 (Del. Super. Ct. Jan. 3, 2013) (quoting Kennedy v. Invacare, Inc., 2006 WL 488590, at *1 (Del. Super. Jan. 31, 2006)). 18 Id.

-3- 1. API’s motion is DENIED regarding the Court’s use of $871 million as the represented value for damages. In API’s motion for reargument, it suggests that the Court mistakenly relied

on the $871 million value when it should have used the purchase price as the

transaction’s represented value.19 But API’s framing isn’t accurate. The Court took

issue with the reliability of any estimates due to API’s fraud. It found that “a reliably

accurate valuation of API at the time of sale could be as low as $785.7 million,

compared to the original estimate of $871 million. As such, a truer valuation of API

might be found to be approximately $80 million lower than the purchase price.”20

Due to the unreliability noted (and other factors), the Court based its damages

amount on the $55 million indemnification cap instead.21

At bottom, the Court misapplied neither the law nor the facts.22 API simply

doesn’t agree with the Court’s approach to addressing damages, which is no basis

Rule relief now.23

19 API’s Rule 59 Mot. at 4. 20 Decision After Trial, 2025 WL 1826656, at *20. 21 Id. (“But, the Court finds that the higher estimate of such damages—whether the result of fraudulent inducement or breach of contract, which in this instance are truly inseparable—would be excessive and trigger the indemnification cap of $55 million.”). 22 Even if the Court solely relied on Tyson’s valuation instead of the purchase price (which it didn’t), it wouldn’t be a misapplication of the law. See NetApp, Inc. v. Cinelli, 2023 WL 4925910, at *18 (Del. Ch. Aug. 2, 2023), judgment entered, (Del. Ch. 2023) (stating that “Delaware courts routinely use the purchase price as the starting point for benefit-of-the-bargain damages calculations,” not that it’s the sole method). 23 See Blevins v. Metzgar, 2017 WL 2709748, at *1 (Del. Super. Ct. June 22, 2017) (“motions for reargument should not be used merely to rehash the arguments already decided by the court”) -4- 2. API’s motion is DENIED regarding the Court’s application of the deductible. In API’s motion for reargument, it suggests that the Court erred in applying

the deductible.24 API, in its post-trial briefing, argued that Tyson’s damages fell

below the $4.125 million deductible and treated it as a condition precedent to

recovery.25 In its Decision After Trial, the Court specifically addressed the

applicability of the escrow deductible and disagreed with API’s conclusions.26

In addition, the Court will not subtract the deductible from its awarded $55

million in damages. The Court found the appropriate damages to match the $55

million escrow cap even after considering API’s deductible claims. The damages

will remain as such.

Upon review, the Court does not find any error in its original analysis, and it

does not see the need to revisit failed arguments already rejected by the Court.27

Free access — add to your briefcase to read the full text and ask questions with AI

River Valley Ingredients, LLC v. American Proteins, Inc., (Del. Ct. App. 2025).

River Valley Ingredients, LLC v. American Proteins, Inc. (River Valley Ingredients, LLC v. American Proteins, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Kronenberg v. Katz
872 A.2d 568 (Court of Chancery of Delaware, 2004)
Gonsalves v. Straight Arrow Publishers, Inc.
701 A.2d 357 (Supreme Court of Delaware, 1997)